UiPath (NYSE:PATH) Price Target Cut to $13.00 by Analysts at DA Davidson

UiPath (NYSE:PATH) had its price objective dropped by DA Davidson from $15.00 to $13.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. DA Davidson’s price target indicates a potential upside of 15.43% from the company’s previous close.

PATH has been the subject of several other reports. BMO Capital Markets boosted their price objective on shares of UiPath from $13.00 to $17.00 and gave the company a “market perform” rating in a research report on Thursday, December 4th. Truist Financial set a $17.00 target price on shares of UiPath in a research report on Thursday, December 4th. Morgan Stanley decreased their price target on shares of UiPath from $19.00 to $17.00 and set an “equal weight” rating for the company in a research note on Thursday. TD Cowen reiterated a “hold” rating on shares of UiPath in a report on Thursday, December 4th. Finally, Barclays raised their price objective on UiPath from $16.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, January 12th. Two investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, UiPath currently has an average rating of “Hold” and an average target price of $14.86.

UiPath Stock Performance

PATH stock traded down $1.12 during midday trading on Thursday, reaching $11.26. The company’s stock had a trading volume of 31,561,519 shares, compared to its average volume of 33,505,078. UiPath has a 1 year low of $9.38 and a 1 year high of $19.84. The firm has a market capitalization of $6.02 billion, a price-to-earnings ratio of 27.38, a PEG ratio of 1.58 and a beta of 1.09. The stock has a fifty day simple moving average of $13.15 and a two-hundred day simple moving average of $13.99.

UiPath (NYSE:PATH) last issued its earnings results on Wednesday, March 11th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. The firm had revenue of $481.11 million during the quarter, compared to analyst estimates of $464.81 million. UiPath had a net margin of 14.79% and a return on equity of 3.73%. The business’s revenue was up 13.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.26 earnings per share. As a group, analysts forecast that UiPath will post -0.17 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Daniel Dines sold 45,000 shares of the stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $15.73, for a total transaction of $707,850.00. Following the transaction, the chief executive officer directly owned 28,343,585 shares in the company, valued at approximately $445,844,592.05. This trade represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Ashim Gupta sold 67,468 shares of UiPath stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the transaction, the chief financial officer directly owned 557,028 shares in the company, valued at approximately $8,968,150.80. The trade was a 10.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 832,468 shares of company stock worth $13,668,235. Insiders own 23.19% of the company’s stock.

Institutional Investors Weigh In On UiPath

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in UiPath by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 49,114,941 shares of the company’s stock worth $804,994,000 after purchasing an additional 1,219,057 shares during the last quarter. TFG Asset Management GP Ltd raised its holdings in shares of UiPath by 53.3% in the second quarter. TFG Asset Management GP Ltd now owns 13,722,244 shares of the company’s stock worth $175,645,000 after buying an additional 4,772,244 shares during the last quarter. State Street Corp raised its holdings in shares of UiPath by 66.4% in the fourth quarter. State Street Corp now owns 13,004,786 shares of the company’s stock worth $213,148,000 after buying an additional 5,189,438 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of UiPath by 76.0% during the second quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company’s stock worth $145,732,000 after buying an additional 4,926,341 shares during the period. Finally, Morgan Stanley lifted its stake in shares of UiPath by 54.0% during the fourth quarter. Morgan Stanley now owns 9,310,304 shares of the company’s stock worth $152,596,000 after buying an additional 3,262,930 shares during the period. 62.50% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting UiPath

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: Q4 beat — UiPath reported revenue of $481.1M and non‑GAAP EPS $0.30, both topping Street expectations; ARR grew to $1.853B, supporting the company’s narrative of enterprise AI adoption moving to scaled deployment. Read More.
• Positive Sentiment: Capital return and long‑term targets — management set a $2B ARR target for FY27 and unveiled a $500M buyback, which reduces float and can support EPS and investor sentiment over time. Read More.
• Neutral Sentiment: Near‑term revenue guide mostly in line — UiPath gave Q1 revenue guidance slightly above Street at the midpoint (~$397.5M), which is a modest beat but not strong enough to offset concerns about FY growth deceleration. Read More.
• Neutral Sentiment: Unusual options activity — elevated call buying (≈94,510 contracts) signals active trader interest but could reflect short‑term speculation rather than conviction.
• Negative Sentiment: Guidance and growth deceleration spooked investors — despite the beat, management’s outlook implies slower full‑year revenue growth, prompting a post‑earnings selloff and after‑hours slide. Read More.
• Negative Sentiment: Analyst pushback — Morgan Stanley cut its price target from $19 to $17 and moved to an “equal weight” stance, a sign some sell‑side desks are trimming expectations despite upside potential cited. Read More.
• Negative Sentiment: Market skepticism remains — commentary highlights decelerating revenue growth and questions about how much AI adoption will translate into sustained upside, keeping the bull case tempered. Read More.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.